General Information of the Compound
Compound ID |
CP0671597
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
Stanozolol
Show/Hide
|
||||||||||||||||||
Synonyms |
10418-03-8
2'H-Androst-2-eno(3,2-c)pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-
4R1VB9P8V3
Anabol
Androstanazol
Androstanazole
Androstanazole (VAN)
Androstanazolestanazol
CHEBI:9249
EINECS 233-894-8
Estanozolol
Estanozolol [INN-Spanish]
Estazol
HSDB 3185
NSC 233046
NSC 43193
Stanazolol
Stanozolo [DCIT]
Stanozolol
Stanozolol (1'H form)
Stanozolol (2'H form)
Stanozololum
Stanozololum [INN-Latin]
Stromba
Strombaject
Tevabolin
UNII-4R1VB9P8V3
WIN 14833
Winstroid
Winstrol
Winstrol Depot
Winstrol V
Winstrol-V
stanozolol
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C21H32N2O
|
||||||||||||||||||
Molecular Weight |
328.5
|
||||||||||||||||||
Canonical SMILES |
C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
LKAJKIOFIWVMDJ-IYRCEVNGSA-N
|
||||||||||||||||||
CAS |
10418-03-8
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01049, Cytochrome P450 2C19
Protein ID: PT00905, Cytochrome P450 2C9
Protein ID: PT00817, Cytochrome P450 2D6
Protein ID: PT00886, Estrogen receptor
Clinical Information about the Compound